Darius-Stefan Amarie

Mr. Darius-Stefan Amarie

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2026 in Medicina
Verified
Journal Article
Open access
PDF file
PSPopa Stefan-Lucian
Popa Stefan-Lucian
Victor InczeVictor Incze
Victor Incze
Abdulrahman IsmaielAbdulrahman Ismaiel
Abdulrahman Ismaiel
TBTeodora Surdea Blaga
Teodora Surdea Blaga
Simona Mihaela GradSimona Mihaela Grad
Simona Mihaela Grad
DDDinu Iuliu Dumitrascu
Dinu Iuliu Dumitrascu
Background and Objectives: Procalcitonin (PCT) is widely used to support the diagnosis of bacterial infection and sepsis, yet clinically relevant elevations also occur in multiple non-infectious conditions. This systematic review aimed to synthesize human evidence on non-infectious causes of elevated PCT and to summarize proposed pathophysiological mechanisms, with the goal of supporting context-based interpretation in clinical practice. Materials and Methods: A systematic search of PubMed/MEDLINE, Embase, Web of Science, and Scopus was performed from inception to 31 July 2025. Human studies published in English reporting quantitative PCT values in non-infectious contexts were eligible (observational studies, clinical trials, and case series with ≥5 patients). Results: Seventy-six unique studies were included. Evidence was organized across systemic inflammatory responses, cardiovascular pathology, nephrological disorders and renal replacement therapy, pulmonary diseases, gastrointestinal and hepatopancreatic diseases, autoimmune and rheumatologic conditions, neurologic and ophthalmologic conditions, onco-hematologic disorders, surgery, traumatology and transplanted patients. Across conditions, non-infectious PCT elevations were variable and frequently overlapped with ranges reported in bacterial infection, particularly in settings characterized by severe sterile inflammation and tissue injury (e.g., major surgery, trauma, shock, pancreatitis, and burns), as well as in selected malignancies with tumor-associated PCT production. Conclusions: Elevated PCT is not synonymous with bacterial infection. Interpretation should emphasize clinical context, timing, and serial trends rather than isolated thresholds, especially in high-acuity settings with strong non-infectious inflammatory stimuli. Standardized reporting of assays and sampling time points and condition-specific kinetic data are needed to refine diagnostic and stewardship algorithms.

26 March 2026 in Medicina
Verified
Journal Article
Open access
PDF file
DDDinu Iuliu Dumitrascu
Dinu Iuliu Dumitrascu
PSPopa Stefan-Lucian
Popa Stefan-Lucian
Victor InczeVictor Incze
Victor Incze
DADarius-Stefan Amarie
Darius-Stefan Amarie
Leo GASPARILeo GASPARI
Leo GASPARI
IMIrina Magurean
Irina Magurean
Artificial intelligence (AI) is increasingly reshaping esthetic and reconstructive plastic surgery by improving measurement accuracy, treatment planning, and prediction of surgical outcomes. This article provides a scientific overview of current AI applications, including automated image analysis, machine-learning-based outcome forecasting, and generative models for preoperative simulation. AI-driven three-dimensional morphometrics allow precise, reproducible quantification of facial and body structures, supporting more objective assessments of symmetry, proportion, and contour. Predictive algorithms trained on large clinical datasets can estimate postoperative results and complication risks with higher consistency than traditional subjective evaluation. Intraoperative AI tools, such as real-time image guidance and robotic assistance, show potential to increase procedural precision and reduce variability. Despite these advances, important limitations persist. Algorithmic bias, restricted data diversity, opaque model architectures, and unresolved ethical concerns regarding data privacy and esthetic standardization challenge widespread clinical adoption. Overall, AI offers a powerful framework for enhancing precision and reproducibility in esthetic surgery, but its safe and responsible integration will require rigorous validation, transparent methodology, and continued human oversight.